Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer
Clinical trial NCT05340374 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05340374
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-14
- Primary completion
- 2026-06-20
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.